Drug
Cannabidivarin clinical trials
Also written CBDV and GWP42006.
- studies test it
- 7
- open now
- 1
- in phase 3
- 0
- first study started
- 2013
Keep track of what changes. Save the cannabidivarin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
7 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 5
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 3
Jazz Pharmaceuticals (4) · King's College London (1) · Montefiore Medical Center (1) · Eric Hollander (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cannabidivarin is read from its arms, and is right about nine times in ten.
Testing it · 7
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)RecruitingPhase 2Montefiore Medical CenterNCT03202303Written as Cannabidivarin
- CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)TerminatedPhase 2Eric HollanderNCT03848481Written as CBDV Compound
- Shifting Brain Excitation-Inhibition Balance in Autism Spectrum DisorderCompletedNot applicableKing's College LondonNCT03537950Written as CBDV
- A Study of the Safety and Tolerability of GWP42006 in Healthy SubjectsCompletedPhase 1Jazz PharmaceuticalsNCT01918735Written as GWP42006
- A Study of GWP42006 in People With Focal Seizures - Part BCompletedPhase 2Jazz PharmaceuticalsNCT02365610Written as GWP42006
- A Study of GWP42006 in People With Focal Seizures - Part ACompletedPhase 2Jazz PharmaceuticalsNCT02369471Written as GWP42006
- Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum DisorderTerminatedPhase 2Jazz PharmaceuticalsNCT03849456Written as GWP42006
Codes
What other systems call cannabidivarin · ClinicalTrials.gg INT006269
- MeSH (NLM) C580853cannabidivarinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) I198VBV98ICANNABIDIVARINConfirmed NLM, Wikidata
- Wikidata Q76421750CannabidivarinConfirmed NLM, Wikidata
- DrugBank DB14050One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C580853 | cannabidivarin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | I198VBV98I | CANNABIDIVARIN | Confirmed NLM, Wikidata |
| Wikidata | Q76421750 | Cannabidivarin | Confirmed NLM, Wikidata |
| DrugBank | DB14050 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.